Sage Therapeutics Cash from Investing (TTM) Trends

Sage Therapeutics Inc (SAGE)

11.70 -0.31 (-2.58%) USD | NASDAQ | May 17, 16:00

11.70 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	387.48M
December 31, 2023	442.91M
September 30, 2023	490.63M
June 30, 2023	441.19M
March 31, 2023	529.86M
December 31, 2022	325.43M
September 30, 2022	205.40M
June 30, 2022	69.46M
March 31, 2022	-353.19M
December 31, 2021	-1.002B
September 30, 2021	-926.67M
June 30, 2021	-888.17M
March 31, 2021	-422.40M
December 31, 2020	442.68M
September 30, 2020	379.25M
June 30, 2020	573.52M
March 31, 2020	338.02M
December 31, 2019	-143.16M
September 30, 2019	-86.82M
June 30, 2019	-294.55M
March 31, 2019	-474.57M

Date	Value
December 31, 2018	-512.46M
September 30, 2018	-655.48M
June 30, 2018	-611.66M
March 31, 2018	-328.94M
December 31, 2017	15.46M
September 30, 2017	2.126M
June 30, 2017	-69.46M
March 31, 2017	-198.07M
December 31, 2016	-230.02M
September 30, 2016	-112.12M
June 30, 2016	-84.37M
March 31, 2016	-0.429M
December 31, 2015	-0.198M
September 30, 2015	-0.205M
June 30, 2015	-0.304M
March 31, 2015	-0.235M
December 31, 2014	-0.128M
September 30, 2014	-0.083M
June 30, 2014	-0.005M
March 31, 2014	-0.003M
December 31, 2013	-0.003M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-1.002B

Minimum

Dec 2021

573.52M

Maximum

Jun 2020

25.42M

Average

265.41M

Median

Cash from Investing (TTM) Benchmarks